Olema Pharmaceuticals, Inc. (OLMA) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 513.23M | 515.45M | 334.33M | 367.73M | 396.66M | 438.47M | 217.99M | 242.19M | 252.09M | 266.51M | 282.01M | 171.51M | 189.4M | 208.9M | 225.06M | 243.03M | 270.21M | 290.69M | 308.28M | 320.85M |
| Cash & Short-Term Investments | 505.35M | 505.44M | 328.96M | 361.91M | 392.71M | 434.09M | 214.76M | 239.1M | 248.98M | 261.81M | 276.9M | 167.44M | 185.95M | 204.42M | 222.6M | 240.71M | 267.87M | 287.25M | 305.95M | 318.14M |
| Cash Only | 52.55M | 48.3M | 35.26M | 52.47M | 50.64M | 139.48M | 35.89M | 16.89M | 33.72M | 68.54M | 117.41M | 34.96M | 40.92M | 23.7M | 26.8M | 24.53M | 21.51M | 13.81M | 25.6M | 50.42M |
| Short-Term Investments | 452.8M | 457.14M | 293.7M | 309.44M | 342.07M | 294.61M | 178.88M | 222.21M | 215.26M | 193.27M | 159.49M | 132.49M | 145.04M | 180.72M | 195.8M | 216.19M | 246.36M | 273.44M | 280.36M | 267.72M |
| Accounts Receivable | 0 | 4.06M | 2.97M | 2.75M | 1.92M | 2.12M | 687K | 821K | 664K | 673K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 7.88M | 5.96M | 577K | 423K | 276K | 366K | 188K | 171K | 177K | 1.68M | 3.48M | 2.68M | 1.35M | 1.83M | 1.63M | 967K | 467K | 462K | 432K | 463K |
| Total Non-Current Assets | 17.42M | 17.98M | 18.12M | 14.28M | 12.98M | 12.51M | 12.18M | 12.37M | 11.6M | 10.43M | 10.79M | 6.12M | 6.37M | 6.75M | 6.94M | 7.57M | 7.2M | 5.26M | 1.51M | 1.38M |
| Property, Plant & Equipment | 921K | 1.15M | 1.91M | 2.25M | 1.71M | 2.06M | 2.42M | 2.76M | 3.09M | 3.26M | 3.61M | 3.21M | 3.6M | 2.5M | 4.17M | 4.48M | 4.41M | 4.72M | 975K | 866K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 739K | 683K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 16.5M | 16.83M | 16.22M | 12.03M | 10.53M | 9.76M | 9.76M | 9.61M | 8.52M | 7.17M | 7.18M | 2.9M | 2.77M | 4.25M | 2.77M | 3.1M | 2.79M | 540K | 540K | 510K |
| Total Assets | 530.64M | 533.43M | 352.45M | 382M | 409.64M | 450.98M | 230.17M | 254.56M | 263.69M | 276.94M | 292.8M | 177.62M | 195.77M | 215.65M | 232M | 250.6M | 277.42M | 295.94M | 309.8M | 322.23M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 29.54% | 18.28% | 53.13% | 50.07% | 55.35% | 62.84% | -21.39% | 43.31% | 34.7% | 28.43% | 26.21% | -29.12% | -29.43% | -27.13% | -25.11% | -22.23% | -16.26% | -13.65% | 137.06% | - |
| Total Current Liabilities | 47.17M | 51.8M | 41.66M | 33.16M | 26.06M | 41.76M | 30.7M | 26.54M | 26.22M | 21.62M | 15.97M | 14.83M | 19.41M | 16.55M | 12.55M | 12.31M | 10.17M | 9.02M | 8.9M | 8.15M |
| Accounts Payable | 3.72M | 9.25M | 3.47M | 934K | 151K | 4.46M | 2.69M | 4.35M | 7.66M | 2.7M | 2.21M | 1.63M | 681K | 374K | 14K | 120K | 268K | 23K | 306K | 385K |
| Days Payables Outstanding | 4.91K | 3.13K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 956K | 1.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 42.49M | 32.02M | 5.29M | 3.39M | 0 | 0 | 3.79M | 2.5M | 1.25M | 5.46M | 57K | 91K | 109K | 68K | 147K | 2.41M | 1.32M | 260K | 323K | 2.05M |
| Current Ratio | 10.88x | 9.95x | 8.03x | 11.09x | 15.22x | 10.50x | 7.10x | 9.13x | 9.61x | 12.33x | 17.66x | 11.56x | 9.76x | 12.62x | 17.93x | 19.75x | 26.57x | 32.23x | 34.63x | 39.39x |
| Quick Ratio | 10.88x | 9.95x | 8.03x | 11.09x | 15.22x | 10.50x | 7.10x | 9.13x | 9.61x | 12.33x | 17.66x | 11.56x | 9.76x | 12.62x | 17.93x | 19.75x | 26.57x | 32.23x | 34.63x | 39.39x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3M | 3.07M | 3.31M | 3.6M | 123K | 257K | 562K | 859K | 1.15M | 1.43M | 1.7M | 1.21M | 1.38M | 1.55M | 1.75M | 2.01M | 2.16M | 2.36M | 0 | 0 |
| Long-Term Debt | 0 | 69K | 3M | 3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 310K | 602K | 123K | 257K | 562K | 859K | 1.15M | 1.43M | 1.7M | 1.21M | 1.38M | 1.55M | 1.75M | 2.01M | 2.16M | 2.36M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3M | 3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 50.17M | 54.87M | 44.97M | 36.77M | 26.19M | 42.02M | 31.26M | 27.39M | 27.38M | 23.05M | 17.66M | 16.04M | 20.79M | 18.1M | 14.3M | 14.32M | 12.33M | 11.38M | 8.9M | 8.15M |
| Total Debt | 956K | 1.19M | 4.48M | 4.75M | 1.15M | 1.43M | 1.7M | 1.96M | 2.21M | 2.42M | 2.62M | 2.01M | 2.29M | 2.56M | 2.83M | 3.09M | 3.04M | 3.29M | 0 | 0 |
| Net Debt | -51.59M | -47.11M | -30.78M | -47.72M | -49.49M | -138.05M | -34.19M | -14.93M | -31.51M | -66.12M | -114.78M | -32.95M | -38.63M | -21.14M | -23.97M | -21.44M | -18.47M | -10.52M | -25.6M | -50.42M |
| Debt / Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 480.48M | 478.56M | 307.49M | 345.24M | 383.45M | 408.96M | 198.91M | 227.16M | 236.32M | 253.9M | 275.13M | 161.58M | 174.97M | 197.55M | 217.7M | 236.28M | 265.09M | 284.57M | 300.89M | 314.08M |
| Equity Growth % | 25.3% | 17.02% | 54.59% | 51.98% | 62.26% | 61.08% | -27.7% | 40.59% | 35.06% | 28.52% | 26.38% | -31.61% | -33.99% | -30.58% | -27.65% | -24.77% | -18.69% | -15.84% | 139.93% | - |
| Book Value per Share | 4.67 | 5.24 | 3.59 | 4.04 | 4.49 | 6.96 | 3.47 | 4.04 | 4.25 | 4.63 | 6.12 | 3.97 | 4.34 | 4.92 | 5.44 | 5.92 | 6.65 | 7.16 | 7.60 | 7.97 |
| Total Shareholders' Equity | 480.48M | 478.56M | 307.49M | 345.24M | 383.45M | 408.96M | 198.91M | 227.16M | 236.32M | 253.9M | 275.13M | 161.58M | 174.97M | 197.55M | 217.7M | 236.28M | 265.09M | 284.57M | 300.89M | 314.08M |
| Common Stock | 8K | 8K | 7K | 7K | 7K | 6K | 4K | 4K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
| Retained Earnings | -650.65M | -597.56M | -551.5M | -509.28M | -465.5M | -435.11M | -401.54M | -366.98M | -336.6M | -305.63M | -278.86M | -257.36M | -237.26M | -208.98M | -182.8M | -160.08M | -127.22M | -104.19M | -82.55M | -64.84M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -460K | 621K | 526K | 314K | 420K | 143K | 464K | -118K | -10K | 347K | -241K | -518K | -978K | -1.81M | -2.67M | -2.4M | -1.63M | -149K | 15K | -14K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |